Effects of an antisense oligonucleotide inhibitor of human ICAM-1 on fetal development in rabbits.
The potential for reproductive toxicity of an antisense oligonucleotide designed to inhibit ICAM-1 was evaluated as part of the safety assessment for this compound. The human active ICAM-1 inhibitor (ISIS 2302) is not pharmacologically active in rabbits. Female rabbits were treated once daily on Day 6 through 18 of gestation. Rabbits were treated with 0, 1, 3, and 9 mg/kg ISIS 2302 by daily i.v. injection. Reproductive indices evaluated included estrus cycling, litter parameters, fetal development, and fetal body weight. Concentrations of oligonucleotide in plasma following the last dose, and in selected maternal target organs, placenta, and fetal tissues at scheduled necropsy were also measured. Maternal toxicity was evident as a decreased maternal body weight gain, decreased food consumption, and scant feces at doses > or =3 mg/kg. Increased spleen to body weight ratio and increased mononuclear cell infiltrates were indicative of a proinflammatory effect of ISIS 2302 at the 9 mg/kg dose level. Despite the maternal toxicity, there were no changes in litter parameters or fetal development in rabbits treated with ISIS 2302. The only change was a decrease in fetal body weight at the 9 mg/kg dose level, which was attributed to the maternal toxicity observed. Maternal liver and kidney contained dose-dependent concentrations of oligonucleotide, but there was relatively little or no oligonucleotide measured in placenta or fetal tissues. Thus, there was no dose-dependent exposure and maternal toxicity to ISIS 2302, but no reproductive toxicity in rabbits, and exposure of fetus or pups is negligible.
Henry
Scott P
SP
Isis Pharmaceuticals Inc, Carlsbad, CA 92008, USA. Shenry@isisph.com
Denny
Kevin H
KH
Templin
Mike V
MV
Yu
Rosie Z
RZ
Levin
Arthur A
AA
D000818:Animals; D005260:Female; D047109:Fetal Development / Q000187:drug effects*; D006801:Humans; D007166:Immunosuppressive Agents / Q000633:toxicity*; D018799:Intercellular Adhesion Molecule-1 / Q000737:chemistry* / Q000235:genetics* / Q000378:metabolism; D007668:Kidney / Q000187:drug effects / Q000473:pathology; D008099:Liver / Q000187:drug effects / Q000473:pathology; D008297:Male; D018811:Maternal Exposure; D020319:Oligodeoxyribonucleotides, Antisense / Q000633:toxicity*; D054735:Phosphorothioate Oligonucleotides; D010920:Placenta / Q000187:drug effects / Q000473:pathology; D011817:Rabbits; D012098:Reproduction / Q000187:drug effects*; D013873:Thionucleotides / Q000633:toxicity*
D007166:Immunosuppressive Agents; D020319:Oligodeoxyribonucleotides, Antisense; D054735:Phosphorothioate Oligonucleotides; D013873:Thionucleotides; D018799:Intercellular Adhesion Molecule-1; C089753:alicaforsen